Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback